"La Clinique Clémentville est un établissement de Médecine-Chirurgie-Obstétrique. Établissement privé le plus ancien du coeur de ville, il a su se moderniser pour accueillir notamment aujourd’hui : • le premier pôle privé en cancérologie de Montpellier (chimiothérapie, radiothérapie, chirurgie des cancers mammaires, digestifs, thoraciques, gynécologiques, O.R.L. et maxillo-faciaux, oncologie médicale et onco-hématologie) • une maternité de niveau II A • un pôle chirurgical et médical : sénologie, orthopédie, chirurgie thoracique et vasculaire, chirurgie viscérale et digestive, proctologie, chirurgie de l’obésité, O.R.L., gastro‑entérologie, médecine interne, pneumologie."

During the past decade, Clinique Clémentville conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Clémentville" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 4 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "Clinique Clementville" with 1 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Clémentville" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Clémentville" are "Breast Cancer" (9 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Colorectal Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "Clinique Clémentville" in a lesser frequency.

Most popular intervention types in "Clinique Clémentville" are "Drug" (20 trials), "Procedure" (6 trials), "Radiation" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Gemcitabine" (4 trials), "Paclitaxel" (4 trials), "Pemetrexed" (4 trials) and "Trastuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Clémentville" are 20 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Clémentville". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Clinique Clémentville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Clémentville, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".